1-(4,6-Dimethylpyrimidin-2-yl)-3-(2-methoxyphenyl)guanidine

Catalog No. :
ACKXQI493
CAS No. :
304868-09-5
Molecular Formula :
C14H17N5O
Molecular Weight :
271.32

IUPAC Name:2-(4,6-dimethylpyrimidin-2-yl)-1-(2-methoxyphenyl)guanidine

1-(4,6-Dimethylpyrimidin-2-yl)-3-(2-methoxyphenyl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$247.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,6-Dimethylpyrimidin-2-yl)-3-(2-methoxyphenyl)guanidine
IUPAC Name2-(4,6-dimethylpyrimidin-2-yl)-1-(2-methoxyphenyl)guanidine
MDL No.MFCD01171445
Molecular FormulaC14H17N5O
Molecular Weight271.32
SMILESN=C(NC1=CC=CC=C1OC)NC2=NC(C)=CC(C)=N2
InChI KeyTXLHKMPASGGCKP-UHFFFAOYSA-N
SynonymASISCHEM C33315;AKOS BBS-00005703;N-(4,6-Dimethylpyrimidin-2-yl)-N'-(2-methoxyphenyl)guanidine;1-(4,6-Dimethylpyrimidin-2-yl)-3-(2-methoxyphenyl)guanidine;Guanidine, N-(4,6-dimethyl-2-pyrimidinyl)-N'-(2-methoxyphenyl)-
CAS No.304868-09-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKXQI493 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7 In Stock
  4. Then
  5. ACKXQI493 route product structure diagram
    ACKXQI493304868-09-5
Inquiry

2. ACKXQI493 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMALW908 route compound structure diagram
    ACMALW9084472-44-0 In Stock
  4. Then
  5. ACKXQI493 route product structure diagram
    ACKXQI493304868-09-5
Inquiry

Comments (0)